Prostate cancer is the leading cancer among Kenyan men, with an estimated 3,582 men being diagnosed with the disease at some ...

ORNL is a leader both in developing advanced radiotherapies and in providing the radioisotopes needed for those therapies.

The market for radioligand therapies is expected to grow significantly in the coming years. This is due to the increasing number of patients who are ...

A novel immunotherapy combination is proving to be both safe and manageable for patients with prostate cancer, according to updated Phase 1 trial data presented at the 2026 ASCO Genitourinary Cancers ...

The market for radioligand therapies is expected to grow significantly in the coming years. This is due to the increasing number of patients who are being diagnosed with cancer, the growing ...

In the quest for a good night’s sleep, which supplement reigns supreme? Sleep doctors weigh in on how magnesium and melatonin ...

The actor and director lifts the veil on key scenes from the heart-stopping episode.

Full body scans, IV drips, at-home hyperbaric chambers, cryotherapy - the business of living longer has never been bigger in Australia.

The pharmaceutical and biotech sectors have seen a flurry of executive movement this month, with leadership changes spanning global giants, clinical-stage biotechs, and specialist pharma companies ...

Barksdale Pavilion in Gulfport lived up to its name on Saturday as Visiting Pet Teams of South Mississippi hosted a membership drive. The festival helped raised awareness on the role therapy animals ...

This illustration shows targeted alpha therapy, in which actinium-225 is linked to a targeting molecule that binds to a cancer cell and delivers ...

Discover six prostate cancer companies advancing the next generation of therapies for all stages of the disease.